$256.98
-2.12 (-0.82%)
At Close: Jul 10, 2026
Hodges Capital Management Inc. Buys 7,937 Shares of Johnson & Johnson (NYSE:JNJ)
07:22pm, Monday, 15'th Nov 2021 Transcript Daily
Hodges Capital Management Inc. boosted its position in shares of Johnson & Johnson (NYSE:JNJ) by 19.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,009 shares of the companys stock after buying an additional 7,937 shares during the quarter. Hodges Capital Management Inc.s holdings []
Burt Wealth Advisors Cuts Stake in Johnson & Johnson (NYSE:JNJ)
06:14pm, Monday, 15'th Nov 2021 Transcript Daily
Burt Wealth Advisors lessened its position in shares of Johnson & Johnson (NYSE:JNJ) by 1.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,777 shares of the companys stock after selling 187 shares during the quarter. Johnson & Johnson comprises 0.6% []
City opens booster shots to all adults as cases tick up
05:11pm, Monday, 15'th Nov 2021 Crain''s New York
New Yorkers who got a Moderna or Pfizer dose at least six months ago or the Johnson & Johnson vaccine at least two months ago are eligible To view the full story, click the title link.
Johnson & Johnson Innovation Announces Awardees of the Decoding Disparities QuickFire Challenge
05:02pm, Monday, 15'th Nov 2021 PR Newswire
NEW BRUNSWICK, N.J., Nov. 15, 2021 /PRNewswire/ -- Today Johnson & Johnson Innovation, LLC, together with Janssen Scientific Affairs, LLC, named Camden Coalition of Healthcare Providers, the Department of Psychiatry and the Behavioral Sciences of the Keck School of Medicine, University of
Bath Savings Trust Co Buys 767 Shares of Johnson & Johnson (NYSE:JNJ)
04:24pm, Monday, 15'th Nov 2021 Dakota Financial News
Bath Savings Trust Co lifted its stake in shares of Johnson & Johnson (NYSE:JNJ) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,572 shares of the company’s stock after acquiring an additional 767 shares during the period. Bath Savings […]
Cameroon:Preparations heighten ahead of Coronavirus vaccination campaign
04:13pm, Monday, 15'th Nov 2021 Journal du Cameroun
The Expanded Programme on Immunization, EPI, has stepped up activities ahead of the third phase nationwide vaccination campaign against the COVID-19 which holds from November 17-21. The exercise which falls in line with governments ambitions to meet up with the vaccination target by the end of the year. To that effect, the Expanded Programme on Immunization recently brought together leaders and resource persons from over 2000 communities across the ten regions of Cameroon to engage them in community mobilization ahead of the exercise. On the other hand, Cameroon recently received 198,400 doses of the Astra Zeneca vaccine to boost the vaccination offer during this third phase of the campaign. The vaccine will provide an opportunity for those who have already received their first dose of the vaccine to get the second dose. This arrival also attests to the fact that the health authorities and the government spare no efforts in providing the population with the necessary services they need, like vaccination in order to put an end to the COVID-19 pandemic, Dr Ndula Shalom, Permanent Secretary of the Expanded Programme on Immunization said.
Johnson & Johnson (NYSE:JNJ) Shares Bought by LVM Capital Management Ltd. MI
01:28pm, Monday, 15'th Nov 2021 Dakota Financial News
LVM Capital Management Ltd. MI increased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 0.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 131,632 shares of the companys stock after acquiring an additional 1,084 shares during the period. Johnson & []
Links 16 November 2021
01:01pm, Monday, 15'th Nov 2021 Macro Business
Global Macro / Markets / Investing: Heres how Elon Musks fortune has benefited from taxpayer help CNN Time To Pin A Medal On Larry Summers For His inflation Prediction Issues Insights Johnson & Johnson To Spin Off Consumer Business The Techee Experts say the 4% rule, a popular retirement income strategy, is
Johnson & Johnson to Separate Consumer Health Business into New Company
12:58pm, Monday, 15'th Nov 2021 Smarter Analyst
Johnson & Johnson (JNJ) plans to separate its Consumer Health business into a new publicly-traded company. With this move, JNJ aims to better The post Johnson & Johnson to Separate Consumer Health Business into New Company appeared first on Smarter Analyst .
Should You Buy Johnson & Johnson Before It Splits?
11:43am, Monday, 15'th Nov 2021 The Motley Fool
The world''s largest drugmaker is splitting in two, but what does that mean for shareholders?
At CAGR 7.21 %, Laparoscopy Devices Market Size to hit USD 15.42 Billion by 2025 Says Brandessence Market Research
11:37am, Monday, 15'th Nov 2021 Intrado Digital Media
Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation
Johnson & Johnson''s Breakup: An Excellent Decision
11:00am, Monday, 15'th Nov 2021 Seeking Alpha
A new market study is released on Global "Minimally Invasive Surgical Instruments Market 2021" with data Tables for historical and forecast years represented with Chats & Graphs with easy to understand detailed analysis. When a wide-ranging Minimally Invasive Surgical Instruments
OTC Anti-Infective Drug Market Demands, Trend, Growth, Size and Top Companies Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS
08:41am, Monday, 15'th Nov 2021 OpenPR
The OTC Anti-Infective Drug Market research report is one point solution for businesses to evolve, grow, and mature. It provides real-time data collection methods that can track niche products growth that aligns with your goals. The insights and statistical models
Johnson & Johnson is dividing the company into two separate businesses
05:01am, Monday, 15'th Nov 2021 EconoTimes
Johnson Johnson may be divided soon as there are plans to split it to become two separate companies. With the division, one will operate the pharmaceutical business while the other will be for the consumer
Sign In
Buy JNJ